Fred Eshelman Distinguished Professor
Chair, Division Pharmacoengineering & Molecular Pharmaceutics
Area of Interest
Kristy Ainslie, PhD, applies her knowledge base in biomaterials and immunology to develop new immune-modulatory therapies that treat and prevent infectious and autoimmune diseases.
Her lab aims to design practical and innovative formulations, taking into account the scalable production and applications in developing nations.